Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.66 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.66 |
| ▸ | DGKA | P23743 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 4/20 | 0.58 |
| ▸ | MGLL | Q99685 | 1/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.52 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.52 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.52 |
| ▸ | PRKCA | P17252 | 1/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.52 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.52 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30775153 | 0.96 | FFAR1 (0.71) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL26868705 | 0.96 | FFAR1 (0.71) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL27513328 | 0.95 | FFAR1 (0.66) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL142809 | 0.95 | FFAR1 (0.66) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL16153880 | 0.95 | FFAR1 (0.69) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL12836601 | 0.94 | FFAR1 (0.64) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL3460445 | 0.94 | FFAR1 (0.64) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL17451093 | 0.93 | EPHX2 (0.65) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL2066896 | 0.93 | EPHX2 (0.65) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL12842107 | 0.93 | FFAR1 (0.63) | FFAR1FFAR4DGKAFAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116375396-B | Self-cleaning rock slice real stone paint and preparation method thereof | 天津德普威涂料有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-117777902-A | Bio-based acrylate pressure-sensitive adhesive and preparation method thereof | 厦门纬达树脂有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-116904019-A | Modified glass fiber reinforced nylon composite material and preparation method thereof | 福建师范大学泉港石化研究院 | 2023-10-20 | — | — | CN | claimed |
| CN-116375396-A | Self-cleaning rock slice real stone paint and preparation method thereof | 天津德普威涂料有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-105837893-A | Cold-resistance halogen-free flame-retardant cable and preparation method thereof | 苏州科茂电子材料科技有限公司 | 2016-08-10 | — | — | CN | claimed |
| CN-116348085-B | Branched chain amino acid surfactants for personal care and cosmetic products | 艾德凡斯化学公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119970540-A | Branched chain amino acid surfactants for personal care and cosmetic products | 艾德凡斯化学公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-116375396-B | Self-cleaning rock slice real stone paint and preparation method thereof | 天津德普威涂料有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-115515557-B | Surfactants for personal care and cosmetic products | 艾德凡斯化学公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-117777902-A | Bio-based acrylate pressure-sensitive adhesive and preparation method thereof | 厦门纬达树脂有限公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20240074973-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2024-03-07 | — | — | US | disclosed |
| US-20240058356-A1 | PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF AND CONTAINING SULFUR-BASED ANTIOXIDANT | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2024-02-22 | — | — | US | disclosed |
| US-20070179211-A1 | Energy-curable intaglio printing | SUN CHEMICAL CORPORATIN (US) | 2007-08-02 | — | — | US | disclosed |
| CN-1961052-A | Energy curable intaglio printing inks | SUN CHEMICAL CORP (US) | 2007-05-09 | — | — | CN | disclosed |
| EP-1751241-A1 | ENERGY-CURABLE INTAGLIO PRINTING INKS | Sun Chemical Corporation (US) | 2007-02-14 | — | — | EP | disclosed |
| WO-2005097927-A1 | ENERGY-CURABLE INTAGLIO PRINTING INKS | SUN CHEMICAL CORPORATION (US) | 2005-10-20 | — | — | WO | disclosed |
| CN-1553796-A | Compositions having enhanced deposition of topically active compounds on surfaces | �йȲ��� | 2004-12-08 | — | — | CN | disclosed |
| CN-1522150-A | Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue | Ī��ҩ��ɷ����Ϲ�˾ | 2004-08-18 | — | — | CN | disclosed |
| CN-1481234-A | Skin oils consisting of oil-soluble constitents | Ī��ҩ��ɷ����Ϲ�˾ | 2004-03-10 | — | — | CN | disclosed |
| CN-1481231-A | Vesicle forming skin oil contg W/O-emulsifiers with hydrophilic-lipophilic balance of 2-6, method for prodn and use thereof | Ī��ҩ��ɷ����Ϲ�˾ | 2004-03-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240058356-A1 | PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF AND CONTAINING SULFUR-BASED ANTIOXIDANT | TXNRD3, TXNRD1, SMOX | FFAR1 2484/4885FFAR4 3004/4885DGKA 4235/4885 |
| US-20240074973-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF | ASAH2, ASAH1, ACER2 | FFAR1 2834/4885FFAR4 3635/4885DGKA 2759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.